Biomarin Pharmaceutical BMRN
$60.41 −$1.01 (-1.64%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $60.02 -0.65%
Open$61.53
Prev close$61.42
Day range$59.84 – $62.01
Volume6.06M
Market cap$11.70B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts23
Average target$88.73+46.9% vs. price
- Buy 74%
- Hold 26%
Low $60.00Now $60.41Avg $88.73High $120.00
Recent rating changes
The last 20 actions on file set price targets from $60.00 to $122.00, averaging $91.85.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | Morgan Stanley | BUY | $103.00 |
| 13 Nov 2026 | Evercore | BUY | $120.00 |
| 4 Nov 2026 | H.C. Wainwright | HOLD | $60.00 |
| 4 Nov 2026 | Barclays | BUY | $114.00 |
| 4 Nov 2026 | J.P. Morgan | BUY | $86.00 |
| 3 Nov 2026 | TD Cowen | BUY | $120.00 |
| 3 Nov 2026 | Wells Fargo | BUY | $80.00 |
| 3 Nov 2026 | UBS | BUY | $88.00 |
| 3 Nov 2026 | Wedbush | BUY | $89.00 |
| 3 Nov 2026 | Morgan Stanley | BUY | $119.00 |
| 3 Nov 2026 | Stifel | HOLD | $66.00 |
| 3 Nov 2026 | H.C. Wainwright | HOLD | $60.00 |
| 3 Nov 2026 | Oppenheimer | BUY | $94.00 |
| 2 Nov 2026 | Cantor Fitzgerald | BUY | $86.00 |
| 2 Nov 2026 | BofA Securities | BUY | $83.00 |
| 2 Nov 2026 | Morgan Stanley | BUY | $122.00 |
| 2 Nov 2026 | BMO Capital | BUY | $97.00 |
| 2 Nov 2026 | Citi | BUY | $76.00 |
| 2 Nov 2026 | RBC Capital | HOLD | $60.00 |
| 29 Oct 2026 | CCORF | BUY | $114.00 |
No comments yet — be the first to weigh in on BMRN.
Sign in to join the discussion.